In the rare studies on the use of lncRNA to construct a diagnostic model for MASLD, lnc PVT1 and HCG18 can well distinguish MASLD patients from normal controls, with diagnostic efficiencies of 0.895 and 0.934, respectively [87,89]. Here, PVT1 is linked to metabolic dysfunction-associated steatotic liver disease.